mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-07 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-07 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-07 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-06 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-06 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-06 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-06 |